NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
Back to search
Official data from USPTO
PERSISTA BIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PERSISTA BIO
ST13
US500000097800116Class
5, 10, 42
Filing
97800116
Registration
7907365
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
08/19/2025
Trademark type
Word
Nice classes
5, 10, 42
Filing date
02/17/2023
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
08/19/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/11/2023
First use in commerce
06/20/2024
Drawing code
4
Owner type
03
Owner location
Ithaca, NY
Examiner
KHOURI, SANI PHILIPPE
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PERSISTA BIO INC.
Representatives
Aleksandar Nikolic
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Surgical implants primarily consisting of biological materials; surgical implants consisting of biological materials; surgical implants comprising biological material; surgical implants primarily comprising biological material; medical device surgical implants comprising biological materials; medical device surgical implants primarily comprising biological materials; primarily biological tissues in the nature of surgical implants; biological tissues in the nature of surgical implants; medical device surgical implants primarily comprising biological materials for cell therapy; medical device surgical implants comprising biological materials for cell therapy; natural biomaterials implant for cell therapy; surgical implants comprising living tissue for oxygen devices; surgical implants primarily comprising living tissue for oxygen devices; surgical implants comprising biological material for oxygen devices; surgical implants primarily comprising biological material for oxygen devices; drug delivery surgical implants comprising biological material; drug delivery surgical implants primarily comprising biological material
Class 10
Surgical implants primarily consisting of artificial materials; surgical implants primarily comprising artificial materials; artificial tissues in the nature of surgical implants consisting of biological materials; biological tissues in the nature of surgical implants consisting of artificial materials; medical device surgical implants primarily comprised of artificial materials for cell therapy; medical device surgical implants primarily comprising artificial material for cell therapy; artificial biomaterial surgical implant for cell therapy; oxygen device surgical implants primarily comprising artificial material; oxygen device surgical implants primarily comprising artificial biomaterial; artificial biomaterial surgical implants for providing oxygen; artificial biomaterials drug delivery surgical implants; drug delivery surgical implants primarily comprising artificial materials; drug delivery surgical implants comprising artificial biomaterial
Class 42
Research and development and consultation related thereto in the field of medical devices; Research and development in the field of medical devices; Research and development and consultation related thereto in the field of biotechnology and biomedical devices; Research and development in the field of biotechnology and biomedical devices; Biochemical research; Biological research; Biotechnology research; Consulting services for others in the field of designplanningimplementation project management of biotechnology and biomedical devices; Medical research; Product research; Product research and development; Scientific research and development
Publications
History of USPTO decisions and trademark events.
22 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/31/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/31/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/30/2025
IUAF
USE AMENDMENT FILED
10/24/2024
EISU
TEAS STATEMENT OF USE RECEIVED
10/24/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/30/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/05/2024
PUBO
PUBLISHED FOR OPPOSITION
03/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/14/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/14/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/26/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/25/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/24/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/24/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/21/2023
GNRT
NON-FINAL ACTION E-MAILED
11/21/2023
CNRT
NON-FINAL ACTION WRITTEN
11/21/2023
DOCK
ASSIGNED TO EXAMINER
11/16/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/08/2023
NWAP
NEW APPLICATION ENTERED
02/21/2023
Continuous trademark protection
Get notified about every new filing that threatens PERSISTA BIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.